View the 1-year data from the DurAVR® THV First-In-Human study presented at EuroPCR 2023 by Dr Susheel Kodali. Excellent hemodynamic results are sustained to 1 year.
We use cookies to enhance your browsing experience and analyze site
traffic. By clicking "Accept," you consent to our use of cookies. For
more information, please read our Privacy Policy